Literature DB >> 27033207

Structural insight for substrate tolerance to 2-deoxyribose-5-phosphate aldolase from the pathogen Streptococcus suis.

Thinh-Phat Cao1,2, Joong-Su Kim3, Mi-Hee Woo3, Jin Myung Choi1,4, Youngsoo Jun4,5, Kun Ho Lee2,6, Sung Haeng Lee7.   

Abstract

2-deoxyribose-5-phosphate aldolase (DERA) is a class I aldolase that catalyzes aldol condensation of two aldehydes in the active site, which is particularly germane in drug manufacture. Structural and biochemical studies have shown that the active site of DERA is typically loosely packed and displays broader substrate specificity despite sharing conserved folding architecture with other aldolases. The most distinctive structural feature of DERA compared to other aldolases is short and flexible C-terminal region. This region is also responsible for substrate recognition. Therefore, substrate tolerance may be related to the C-terminal structural features of DERA. Here, we determined the crystal structures of full length and C-terminal truncated DERA from Streptococcus suis (SsDERA). In common, both contained the typical (α/β)8 TIM-barrel fold of class I aldolases. Surprisingly, C-terminal truncation resulting in missing the last α9 and β8 secondary elements, allowed DERA to maintain activity comparable to the fulllength enzyme. Specifically, Arg186 and Ser205 residues at the C-terminus appeared mutually supplemental or less indispensible for substrate phosphate moiety recognition. Our results suggest that DERA might adopt a shorter C-terminal region than conventional aldolases during evolution pathway, resulting in a broader range of substrate tolerance through active site flexibility.

Entities:  

Keywords:  2-deoxyribose-5-phosphate aldolase; Class I aldolase; DERA; S. suis; TIM-barrel

Mesh:

Substances:

Year:  2016        PMID: 27033207     DOI: 10.1007/s12275-016-6029-4

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  38 in total

1.  Channelling of deoxyribose moiety of exogenous DNA into carbohydrate metabolism: role of deoxyriboaldolase.

Authors:  F Sgarrella; F P Poddie; M A Meloni; L Sciola; P Pippia; M G Tozzi
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1997-06       Impact factor: 2.231

Review 2.  The discovery and development of HMG-CoA reductase inhibitors.

Authors:  A Endo
Journal:  J Lipid Res       Date:  1992-11       Impact factor: 5.922

3.  Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase.

Authors:  N Blom; J Sygusch
Journal:  Nat Struct Biol       Date:  1997-01

4.  Evidence for the spatial separation of the binding sites for substrate and for cytoskeletal proteins on the enzyme aldolase.

Authors:  L Humphreys; S Reid; C Masters
Journal:  Int J Biochem       Date:  1986

5.  Molecular architecture of rabbit skeletal muscle aldolase at 2.7-A resolution.

Authors:  J Sygusch; D Beaudry; M Allaire
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Limited proteolysis of liver and muscle aldolases: effects of subtilisin, cathepsin B, and Staphylococcus aureus protease.

Authors:  E Hannappel; J S MacGregor; S Davoust; B L Horecker
Journal:  Arch Biochem Biophys       Date:  1982-03       Impact factor: 4.013

7.  Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms.

Authors:  Masoud Vedadi; Jocelyne Lew; Jennifer Artz; Mehrnaz Amani; Yong Zhao; Aiping Dong; Gregory A Wasney; Mian Gao; Tanya Hills; Stephen Brokx; Wei Qiu; Sujata Sharma; Angelina Diassiti; Zahoor Alam; Michelle Melone; Anne Mulichak; Amy Wernimont; James Bray; Peter Loppnau; Olga Plotnikova; Kate Newberry; Emayavaram Sundararajan; Simon Houston; John Walker; Wolfram Tempel; Alexey Bochkarev; Ivona Kozieradzki; Aled Edwards; Cheryl Arrowsmith; David Roos; Kevin Kain; Raymond Hui
Journal:  Mol Biochem Parasitol       Date:  2006-11-13       Impact factor: 1.759

8.  Analysis of the class I aldolase binding site architecture based on the crystal structure of 2-deoxyribose-5-phosphate aldolase at 0.99A resolution.

Authors:  Andreas Heine; John G Luz; Chi-Huey Wong; Ian A Wilson
Journal:  J Mol Biol       Date:  2004-10-29       Impact factor: 5.469

9.  The C-terminal domain of Escherichia coli dihydrodipicolinate synthase (DHDPS) is essential for maintenance of quaternary structure and efficient catalysis.

Authors:  Belinda B B Guo; Sean R A Devenish; Renwick C J Dobson; Andrew C Muscroft-Taylor; Juliet A Gerrard
Journal:  Biochem Biophys Res Commun       Date:  2009-02-04       Impact factor: 3.575

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  3 in total

1.  Rational engineering of 2-deoxyribose-5-phosphate aldolases for the biosynthesis of (R)-1,3-butanediol.

Authors:  Taeho Kim; Peter J Stogios; Anna N Khusnutdinova; Kayla Nemr; Tatiana Skarina; Robert Flick; Jeong Chan Joo; Radhakrishnan Mahadevan; Alexei Savchenko; Alexander F Yakunin
Journal:  J Biol Chem       Date:  2019-12-05       Impact factor: 5.157

2.  Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib.

Authors:  Titto Augustine; Radhashree Maitra; Jinghang Zhang; Jay Nayak; Sanjay Goel
Journal:  Invest New Drugs       Date:  2019-01-05       Impact factor: 3.850

3.  Conformational Sampling of the Intrinsically Disordered C-Terminal Tail of DERA Is Important for Enzyme Catalysis.

Authors:  Marianne Schulte; Dušan Petrović; Philipp Neudecker; Rudolf Hartmann; Jörg Pietruszka; Sabine Willbold; Dieter Willbold; Vineet Panwalkar
Journal:  ACS Catal       Date:  2018-03-27       Impact factor: 13.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.